
Overview
Background
Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Veterinary Biology, The University of Queensland
- Bachelor (Honours) of Veterinary Science, The University of Queensland
- Doctor of Philosophy, The University of Queensland
- Doctoral Diploma, The University of Queensland
Research impacts
Overall goals:
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.
We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.
Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Research interests:
Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.
We have developed and use a number of in vivo models of infectious diseases including:
- Influenza
- Herpes virus
- Lymphocytic choriomeningitis virus (LCMV)
These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.
Works
Search Professor Gabrielle Belz’s works on UQ eSpace
2013
Journal Article
TCF-1 controls ILC2 and NKp46+ RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation
Mielke, Lisa A., Groom, Joanna R., Rankin, Lucille C., Seillet, Cyril, Masson, Frederick, Putoczki, Tracy and Belz, Gabrielle T. (2013). TCF-1 controls ILC2 and NKp46+ RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation. Journal of Immunology, 191 (8), 4383-4391. doi: 10.4049/jimmunol.1301228
2013
Journal Article
The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells
Man, Kevin, Miasari, Maria, Shi, Wei, Xin, Annie, Henstridge, Darren C., Preston, Simon, Pellegrini, Marc, Belz, Gabrielle T., Smyth, Gordon K., Febbraio, Mark A., Nutt, Stephen L. and Kallies, Axel (2013). The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nature Immunology, 14 (11), 1155-1165. doi: 10.1038/ni.2710
2013
Journal Article
Diversity, function, and transcriptional regulation of gut innate lymphocytes
Rankin, Lucille, Groom, Joanna, Mielke, Lisa A., Seillet, Cyril and Belz, Gabrielle T. (2013). Diversity, function, and transcriptional regulation of gut innate lymphocytes. Frontiers in Immunology, 4 (MAR) Article 22. doi: 10.3389/fimmu.2013.00022
2013
Journal Article
Keeping memories alive
Belz, Gabrielle T. and Cretney, Erika (2013). Keeping memories alive. Frontiers in Immunology, 4 (FRB) Article 21. doi: 10.3389/fimmu.2013.00021
2013
Journal Article
Erratum: The transcription factor T-bet is essential for the development of NKp46 + innate lymphocytes via the Notch pathway (Nature Immunology (2013) 14 (389-395))
Rankin, Lucille, Groom, Joanna R., Chopin, Michaël, Herold, Marco J., Walker, Jennifer A., Mielke, Lisa A., Mckenzie, Andrew N. J., Carotta, Sebastian, Nutt, Stephen L. and Belz, Gabrielle T. (2013). Erratum: The transcription factor T-bet is essential for the development of NKp46 + innate lymphocytes via the Notch pathway (Nature Immunology (2013) 14 (389-395)). Nature Immunology, 14 (8), 389-395. doi: 10.1038/ni0813-877b
2013
Journal Article
Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunity
Hawkins, Edwin D., Oliaro, Jane, Kallies, Axel, Belz, Gabrielle T., Filby, Andrew, Hogan, Thea, Haynes, Nicole, Ramsbottom, Kelly M., Van Ham, Vanessa, Kinwell, Tanja, Seddon, Benedict, Davies, Derek, Tarlinton, David, Lew, Andrew M., Humbert, Patrick O. and Russell, Sarah M. (2013). Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunity. Nature Communications, 4 (1) 1801. doi: 10.1038/ncomms2796
2013
Journal Article
Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation
Masson, Frederick, Minnich, Martina, Olshansky, Moshe, Bilic, Ivan, Mount, Adele M., Kallies, Axel, Speed, Terence P., Busslinger, Meinrad, Nutt, Stephen L. and Belz, Gabrielle T. (2013). Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. Journal of Immunology, 190 (9), 4585-4594. doi: 10.4049/jimmunol.1300099
2013
Journal Article
The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway
Rankin, Lucille C., Groom, Joanna R., Chopin, Michael, Herold, Marco J., Walker, Jennifer A., Mielke, Lisa A., McKenzie, Andrew N. J., Carotta, Sebastian, Nutt, Stephen L. and Belz, Gabrielle T. (2013). The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nature Immunology, 14 (4), 389-395. doi: 10.1038/ni.2545
2013
Journal Article
CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3
Seillet, Cyril, Jackson, Jacob T., Markey, Kate A., Brady, Hugh J. M., Hill, Geoffrey R., MacDonald, Kelli P. A., Nutt, Stephen L. and Belz, Gabrielle T. (2013). CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. Blood, 121 (9), 1574-1583. doi: 10.1182/blood-2012-07-445650
2013
Journal Article
MiR-142 keeps CD4+ DCs in balance
Belz, Gabrielle T. (2013). MiR-142 keeps CD4+ DCs in balance. Blood, 121 (6), 871-872. doi: 10.1182/blood-2012-12-472589
2013
Journal Article
Erratum: transcriptional programming of the dendritic cell network (Nature Reviews Immunology (2012) 12 (101-113))
Belz, Gabrielle T. and Nutt, Stephen L. (2013). Erratum: transcriptional programming of the dendritic cell network (Nature Reviews Immunology (2012) 12 (101-113)). Nature Reviews Immunology, 13 (2), 149-149. doi: 10.1038/nri3385
2013
Book Chapter
Terminal differentiation of dendritic cells
Seillet, Cyril and Belz, Gabrielle T. (2013). Terminal differentiation of dendritic cells. Development and Function of Myeloid Subsets. (pp. 185-210) edited by Kenneth M. Murphy and Miriam Merad. Maryland Heights, MO, United States: Academic Press. doi: 10.1016/B978-0-12-417028-5.00007-7
2013
Journal Article
Immunology and Cell Biology Publication of the Year Awards 2012
Belz, Gabrielle (2013). Immunology and Cell Biology Publication of the Year Awards 2012. Immunology and Cell Biology, 91 (10), 595-596. doi: 10.1038/icb.2013.60
2013
Book Chapter
Cytotoxic T lymphocytes and natural killer cells
Nutt, Stephen L., Carotta, Sebastian, Kallies, Axel and Belz, Gabrielle T. (2013). Cytotoxic T lymphocytes and natural killer cells. Clinical immunology: principles and practice: fourth edition. (pp. 215-227) Amsterdam, Netherlands: Elsevier Inc.. doi: 10.1016/B978-0-7234-3691-1.00015-5
2012
Journal Article
Transcriptional regulation of dendritic cell diversity
Chopin, Michaël, Allan, Rhys S. and Belz, Gabrielle T. (2012). Transcriptional regulation of dendritic cell diversity. Frontiers in Immunology, 3 (FEB) Article 26. doi: 10.3389/fimmu.2012.00026
2012
Journal Article
Contrôle épigénétique de la stabilité phénotypique et fonctionnelle des lymphocytes Th2 par la voie Suv39h1/HP1a
Zueva, Elina, Allan, Rhys S., Cammas, Florence, Schreiber, Heidi A., Masson, Vanessa, Belz, Gabrielle T., Roche, Danièle, Maison, Christèle, Quivy, Jean-Pierre, Almouzni, Geneviève and Amigorena, Sebastian (2012). Contrôle épigénétique de la stabilité phénotypique et fonctionnelle des lymphocytes Th2 par la voie Suv39h1/HP1a. Medecine/Sciences, 28 (12), 1032-1034. doi: 10.1051/medsci/20122812003
2012
Journal Article
A new ICB sister journal focuses on clinical and translational immunology
Belz, Gabrielle, Tangye, Stuart G and Liston, Adrian (2012). A new ICB sister journal focuses on clinical and translational immunology. Clinical and Translational Immunology, 1 (11) e1. doi: 10.1038/cti.2012.3
2012
Journal Article
B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1
Karnowski, Alex, Chevrier, Stephane, Belz, Gabrielle T., Mount, Adele, Emslie, Dianne, D'Costa, Kathy, Tarlinton, David M., Kallies, Axel and Corcoran, Lynn M. (2012). B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. Journal of Experimental Medicine, 209 (11), 2049-2064. doi: 10.1084/jem.20111504
2012
Journal Article
An epigenetic silencing pathway controlling T helper 2 cell lineage commitment
Allan, Rhys S., Zueva, Elina, Cammas, Florence, Schreiber, Heidi A., Masson, Vanessa, Belz, Gabrielle T., Roche, Danièle, Maison, Christèle, Quivy, Jean-Pierre, Almouzni, Geneviève and Amigorena, Sebastian (2012). An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature, 487 (7406), 249-253. doi: 10.1038/nature11173
2012
Journal Article
Unlike CD4+ T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity
Seah, Shirley G.K., Carrington, Emma M., Ng, Wy C., Belz, Gabrielle T., Brady, Jamie L., Sutherland, Robyn M., Hancock, Manuela S., La Gruta, Nicole L., Brown, Lorena E., Turner, Stephen J., Zhan, Yifan and Lew, Andrew M. (2012). Unlike CD4+ T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity. European Journal of Immunology, 42 (7), 1744-1754. doi: 10.1002/eji.201142211
Funding
Current funding
Supervision
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Unravelling immune signalling networks in mucosal immunity
Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.
This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.
Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.
The Belz Laboratory
The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.
Frazer Institute at the University of Queensland
The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.
As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.
The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.
With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.
The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.
Supervision history
Current supervision
-
Doctor Philosophy
Studying the tumour immune microenvironment in cutaneous squamous cell carcinoma
Principal Advisor
Other advisors: Associate Professor Arutha Kulasinghe
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Deciphering the protective program of innate and adaptive cells in pathogen infection
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
High Mobility Group Box Family Member TOX2 in Innate Lymphoid Cell Development and Maintenance
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
The role of innate cells in shaping the tumour environment.
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes, Dr M. Zeeshan Chaudhry
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Innate lymphoid cells in tumour control
Principal Advisor
-
Doctor Philosophy
Immune Regulation of Lung Injury: Pathways to Repair, Restoration and Fibrosis
Principal Advisor
Other advisors: Professor Dan Chambers
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Development of natural killer cells with enhanced tumoricidal functions using CRISPR homology-directed repair-mediated gene editing
Associate Advisor
Other advisors: Dr Allie Lam, Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Understanding immune diversity in skin inflammation
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani, Dr Snehlata Kumari
-
Doctor Philosophy
The Ins and Outs of Endocytosis inhibition: Providing diverse opportunities for treatment of incurable cancers
Associate Advisor
Other advisors: Dr Shannon Joseph, Professor Fiona Simpson
-
Doctor Philosophy
Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
Associate Advisor
Other advisors: Dr Nichaela Harbison-Price, Professor Mark Walker
Completed supervision
Media
Enquiries
For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team: